Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: +$36.8K
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 4 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 7 most recent Form 4 transactions.
| Oncotelic Therapeutics,… |
| PBUY |
| 115,000 |
| $0.045 |
| $5.2K |
| +0.1% |
| Open the original filing on SEC.gov |
| Jun 23 | OTLC | Oncotelic Therapeutics,… | PBUY | 75,000 | $0.045 | $3.4K | +<0.1% | Open the original filing on SEC.gov |
| Jun 22 | OTLC | Oncotelic Therapeutics,… | PBUY | 65,000 | $0.045 | $2.9K | +<0.1% | Open the original filing on SEC.gov |
| Jun 17 | OTLC | Oncotelic Therapeutics,… | PBUY | 239,759 | $0.0446 | $10.7K | +0.3% | Open the original filing on SEC.gov |
| Jun 15 | OTLC | Oncotelic Therapeutics,… | PBUY | 96,000 | $0.045 | $4.3K | +0.1% | Open the original filing on SEC.gov |